Comparison of corelease of noradrenaline and ATP evoked by hypogastric nerve stimulation and field stimulation in guinea-pig vas deferens
- PMID: 7477448
- DOI: 10.1007/BF00176779
Comparison of corelease of noradrenaline and ATP evoked by hypogastric nerve stimulation and field stimulation in guinea-pig vas deferens
Abstract
Contractions and overflow of tritium and ATP elicited by hypogastric nerve stimulation (HNS) and field stimulation (FS) were studied in the guinea-pig isolated vas deferens preincubated with [3H]-noradrenaline. ATP was measured by means of the luciferin-luciferase technique. HNS and FS elicited contraction, tritium overflow and ATP overflow. HNS at supramaximal current strength produced smaller responses than did FS at supramaximal current strength (210 pulses/7 Hz). Supramaximal HNS and submaximal FS were used in the remainder of the study. Prazosin (0.3 mumol/l) reduced contractions and the overflow of ATP elicited by both HNS and FS; the evoked overflow of tritium was not changed (210 pulses/7 Hz). Combined administration of prazosin (0.3 mumol/l) and suramin (300 mumol/l) abolished contractions and reduced the overflow of ATP elicited by both HNS and FS slightly more than did prazosin alone; tritium overflow again was not changed (210 pulses/7 Hz). Contractions, tritium overflow and ATP overflow increased with the frequency of both HNS and FS (from 7 to 25 Hz; 210 pulses); the increase in ATP overflow with frequency was more marked than the increase in tritium overflow. The preferential increase of ATP overflow with the frequency of HNS and FS persisted in the combined presence of prazosin (0.3 mumol/l) and suramin (300 mumol/l). The study confirms for HNS, a more physiologic way of sympathetic nerve stimulation, several observations previously obtained with FS. First, HNS-evoked ATP release is detectable as an overflow of ATP into the superfusion fluid.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens.Naunyn Schmiedebergs Arch Pharmacol. 1991 Oct;344(4):419-29. doi: 10.1007/BF00172581. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1662775
-
Neural ATP release and its alpha 2-adrenoceptor-mediated modulation in guinea-pig vas deferens.Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):358-66. doi: 10.1007/BF00171334. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7904050
-
Corelease of noradrenaline and ATP by brief pulse trains in guinea-pig vas deferens.Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):123-9. doi: 10.1007/BF00241085. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7990968
-
P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens.Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):42-8. doi: 10.1007/BF00180009. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7935853
-
Fertility: purinergic receptors and the male contraceptive pill.Curr Biol. 2000 Apr 20;10(8):R305-7. doi: 10.1016/s0960-9822(00)00436-x. Curr Biol. 2000. PMID: 10801405 Review.
Cited by
-
Failure of tyramine to release neuronal ATP as a cotransmitter of noradrenaline in the guinea-pig vas deferens.Naunyn Schmiedebergs Arch Pharmacol. 1996 Jan;353(2):175-83. doi: 10.1007/BF00168755. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8717158
-
Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: evidence for the beta 2 subtype.Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):564-71. doi: 10.1007/BF00169177. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8740151
-
Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine.Hypertension. 2017 Mar;69(3):484-493. doi: 10.1161/HYPERTENSIONAHA.116.08623. Epub 2017 Jan 30. Hypertension. 2017. PMID: 28137984 Free PMC article.
-
Opposite modulation of cotransmitter release in guinea-pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional beta-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 1996 Jan;353(2):184-92. doi: 10.1007/BF00168756. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8717159